Business Context and Reporting Period
This Form 8-K, dated May 30, 2014, reports the completion of The Ensign Group, Inc.'s (Ensign) previously announced spin-off of its real estate business into a separate, independent publicly traded company, CareTrust REIT, Inc. (CareTrust). The distribution of CareTrust shares to Ensign stockholders occurred on June 2, 2014, with the separation effective as of June 1, 2014. Ensign stockholders received one share of CareTrust common stock for each share of Ensign common stock held on the record date of May 22, 2014.
Key Financial Metrics and Capital Structure
Debt and Liquidity:
- New Credit Facility: Ensign entered into a new revolving credit facility with an aggregate principal amount of $150.0 million, secured by substantially all personal property and a pledge of subsidiary capital stock.
- Incremental Capacity: The company may seek incremental loans up to an additional $75.0 million subject to conditions.
- Interest Rates: Loans bear interest at Base Rate plus 1.25% to 2.25% or LIBOR plus 2.25% to 3.25%, based on the debt-to-Consolidated EBITDA ratio.
- Commitment Fee: Ranges from 0.30% to 0.50% per annum on unused commitments.
- Debt Repayment: Outstanding obligations under the prior credit agreement, GECC Loan, HUD Loan, RBS Loans, and Johnson Notes were paid on May 30, 2014, except for the GECC Loan and one Johnson Note, which were assumed by CareTrust.
Cash Consideration: Under the Contribution Agreement, Ensign contributed property entities to CareTrust in exchange for CareTrust common stock and $221.4 million in cash.
Financial Covenants: The new Credit Agreement requires compliance with a maximum debt-to-Consolidated EBITDA ratio and a minimum interest/rent coverage ratio, tested quarterly.
Revenue and Profit: The filing text does not provide specific revenue, profit, or margin figures for the reporting period; it references unaudited pro forma financial statements in Exhibit 99.2.
Material Changes Versus Prior Period
- Corporate Structure: Transition from a combined healthcare and real estate entity to a standalone healthcare operator, with real estate assets transferred to CareTrust.
- Debt Obligations: Termination of the prior Senior Credit Facility (July 2011), GECC Loan, HUD Loan, RBS Loans, and Johnson Notes. Most were paid off; specific real estate-related debt was assumed by CareTrust.
- Executive Leadership: Gregory K. Stapley resigned as Executive Vice President and Secretary to become CEO of CareTrust. Chad A. Keetch was appointed as the new Executive Vice President and Secretary.
- Shareholder Rights: The Company's poison pill (Rights Agreement) expired on June 3, 2014, following the completion of the Spin-Off.
Guidance, Outlook, and Risks
Management Commentary and Agreements: Ensign and CareTrust entered into multiple agreements to govern their post-spin-off relationship, including eight Master Leases, an Opportunities Agreement, a Tax Matters Agreement, a Transition Services Agreement, and an Employee Matters Agreement.
Risks and Contingencies:
- Covenant Compliance: The new Credit Agreement contains restrictive covenants regarding liens, indebtedness, asset sales, and dividends.
- Collateral Requirements: If the debt-to-Consolidated EBITDA ratio exceeds 2.50:1.00 for two consecutive fiscal quarters, or if liquidity falls below a certain threshold for ten consecutive business days, lenders may require mortgages on real property assets.
- Pro Forma Data: Investors are directed to Exhibit 99.2 for unaudited pro forma consolidated financial statements reflecting the Spin-Off.
Key Facts for Investor Verification
- Verify the terms of the $150.0 million new revolving credit facility and the specific financial maintenance covenants in the Credit Agreement (Exhibit 10.8).
- Review the Separation and Distribution Agreement (Exhibit 2.1) to understand the ongoing lease and operational relationships between Ensign and CareTrust.
- Examine the Unaudited Pro Forma Consolidated Financial Statements (Exhibit 99.2) to assess Ensign's standalone financial position post-spin-off.
- Confirm the status of the $221.4 million cash consideration received from CareTrust and its impact on Ensign's liquidity.
- Monitor the expiration of the Rights Agreement and the elimination of Series A Junior Participating Preferred Stock.